Drug can quickly mobilize an army of cells to rep...( To speed healing at sites of injury

Drug can quickly mobilize an army of cells to repair injury

To speed healing at sites of injury - such as heart muscle after a heart attack or brain tissue after a stroke - doctors would like to be able to hasten the formation of new blood vessels. One promising approach is to "mobilize" patients' blood vessel-forming cells, called angiogenic cells, so these cells can reach the injured area.

Recently, researchers at Washington University School of Medicine in St. Louis demonstrated that a drug called AMD3100 can mobilize angiogenic cells from bone marrow of human patients in a matter of hours instead of days, as was the case with a related agent called G-CSF.

Angiogenic cells reside mainly in the bone marrow, and when mobilized they can circulate in the bloodstream, homing to sites of injury and helping repair and regrow blood vessels that bring oxygen and nutrients to tissues.

"Like AMD3100, G-CSF can bring these beneficial cells from the bone marrow into the bloodstream, but with G-CSF you don't see an increase in angiogenic cells until the fourth day," says senior author Daniel C. Link, M.D., associate professor of medicine in the Division of Oncology. "In a patient who has had a heart attack, that may be too late. In fact, two clinical trials of G-SCF found the treatment doesn't improve recovery from heart attacks."

In an article in the journal Blood, the researchers showed that AMD3100 caused a 10- to 20-fold increase in certain angiogenic cells in the blood within four hours in human subjects, suggesting the drug could be a more effective treatment for heart attack or stroke.

The ability of angiogenic cells to enhance recovery from heart attack has become a hot research topic, according to Link, with several clinical trials investigating whether withdrawing bone marrow from a patient and then injecting it at the site of injury will be effective. But Link feels it may make more sense to mobilize the cells into the bloodstream with agents like AMD3100.

"It might be
'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
7-Sep-2006

Page: 1 2
Related medicine news :

1. Resistant HIV quickly hides in infants cells
2. Inexpensive test detects H5N1 infections quickly and accurately
3. Large subset of learning disabled children can be quickly identified by new diagnostic device
4. Researchers find nicotine withdrawal begins quickly
5. New MRI technique quickly builds 3-D images of knees
6. FDA should approve emergency contraceptive Plan B quickly to demonstrate its independence
7. UQ research will move medicines to market more quickly
8. Strokes in children need to be recognized quickly
9. Mayo researchers seek methods to make new cancer therapies available more quickly
10. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
11. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer

Post Your Comments: